000			01931 a2200517 4500
005			20250518101003.0
264		0	_c20201211
008			202012s 0 0 eng d
022			_a1549-4713
024	7		_a10.1016/j.ophtha.2020.02.027 _2doi
040			_aNLM _beng _cNLM
100	1		_aKiss, Szilárd
245	0	0	_aManagement and Outcomes for Neovascular Age-Related Macular Degeneration: Analysis of United States Electronic Health Records. _h[electronic resource]
260			_bOphthalmology _c09 2020
300			_a1179-1188 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aBevacizumab _xtherapeutic use
650	0	4	_aChoroidal Neovascularization _xdrug therapy
650	0	4	_aCohort Studies
650	0	4	_aElectronic Health Records _xstatistics & numerical data
650	0	4	_aFemale
650	0	4	_aFluorescein Angiography
650	0	4	_aHumans
650	0	4	_aIntravitreal Injections
650	0	4	_aMale
650	0	4	_aRanibizumab _xtherapeutic use
650	0	4	_aReceptors, Vascular Endothelial Growth Factor _xtherapeutic use
650	0	4	_aRecombinant Fusion Proteins _xtherapeutic use
650	0	4	_aRetrospective Studies
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States
650	0	4	_aVascular Endothelial Growth Factor A _xantagonists & inhibitors
650	0	4	_aVisual Acuity _xphysiology
650	0	4	_aWet Macular Degeneration _xdrug therapy
700	1		_aCampbell, Joanna
700	1		_aAlmony, Arghavan
700	1		_aShih, Vanessa
700	1		_aSerbin, Michael
700	1		_aLaPrise, Andrew
700	1		_aWykoff, Charles C
773	0		_tOphthalmology _gvol. 127 _gno. 9 _gp. 1179-1188
856	4	0	_uhttps://doi.org/10.1016/j.ophtha.2020.02.027 _zAvailable from publisher's website
999			_c30911397 _d30911397